Upgrade to SI Premium - Free Trial

Canaccord Genuity Raises Price Target on Aquinox Pharma (AQXP) to $22 on Supporting Evidence for AQX-1125

September 11, 2015 9:24 AM
Canaccord Genuity reiterated a Buy rating on Aquinox Pharmaceutical (NASDAQ: AQXP), and raised the price target to $22.00 (from $10.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst PT Change

Next Articles